Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Stocks to Buy for Their Massive Upside Potential

By Josh Enomoto, InvestorPlace Contributor

While blue chips are relatively predictable, they’re also boring. For serious gains, you need to check out these stocks to buy now.

Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich… or Broke.

By Josh Enomoto, InvestorPlace Contributor

While lesser-known enterprises present viability risks, those wanting to swing for the fences should seek small-cap stocks to buy.

7 Short-Interest Stocks to Target for Explosive Gains

By Josh Enomoto, InvestorPlace Contributor

For contrarian investors that can stand the heat, short-interest stocks to buy can offer significant rewards in a short time period.

Why Is Palantir (PLTR) Stock Up 10% Today?

By Josh Enomoto, InvestorPlace Contributor

Palantir Technologies continues to ride the sentiment associated with its strong Q1 report, though some questions linger.

Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?

By Josh Enomoto, InvestorPlace Contributor

Enveric Biosciences’ Notice of Allowance for a therapeutic patent is bolstering ENVB stock, but investors should exercise caution.

Load More